Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients
NCT02075606
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
NeuroEndocrine Tumours
Interventions
DRUG:
lanreotide acetate
Sponsor
Ipsen